NPDC1
(Neural Proliferation, Differentiation and Control, 1 (NPDC1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-NPDC1 antibody (Catalog #: ARP47153_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
NPDC1
(Neural Proliferation, Differentiation and Control, 1 (NPDC1))
Synonyme
AI314472 Peptide, NPDC-1 Peptide, CAB Peptide, CAB- Peptide, CAB-1 Peptide, CAB1 Peptide, neural proliferation, differentiation and control, 1, gene 1 L homeolog Peptide, neural proliferation, differentiation and control 1 Peptide, neural proliferation, differentiation and control, 1 Peptide, npdc1.1.L Peptide, Npdc1 Peptide, NPDC1 Peptide
Hintergrund
NPDC1 suppresses oncogenic transformation in neural and non-neural cells and down-regulates neural cell proliferation. It might be involved in transcriptional regulation.
Alias Symbols: CAB, CAB-, CAB-1, CAB1, DKFZP586J0523, NPDC-1
Protein Interaction Partner: CCND1,CCND2,CCND3,CDK2,E2F1,HNRNPK,KRTAP4-12,MADD,MDFI,NPDC1,PLSCR1,TFDP1,CCND1,CCND2,CCND3,CDK2,E2F1,HNRNPK,KRTAP4-12,MDFI,PLSCR1,TFDP1